🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kodye L. Abbott

Yale University

ORCID: 0000-0002-1439-1060

Pharmacology, Toxicology and PharmaceuticsMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice”.

A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice

Liver Research(2021)10.1016/j.livres.2021.04.002

N/A

0DataRank · unranked

12 citations

Julia M. Salamat, Kodye L. Abbott, Patrick Flannery, Mohammed Majrashi, Mohammed Almaghrabi +14 more

Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation

npj Systems Biology and Applications(2024)10.1038/s41540-024-00400-1

N/A

0DataRank · unranked

4 citations

Kodye L. Abbott, Nadia Arang, Kathryn Lande, Navneet Kaur, Melinda Tong +4 more

Mathematical modeling suggests 14-3-3 proteins modulate RAF paradoxical activation

PLoS Computational Biology(2025)10.1371/journal.pcbi.1013297

N/A

0DataRank · unranked

0 citations

Kodye L. Abbott, Yaocheng Li, Jingting Yu, Peter Carlip, Melinda Tong +6 more